secwatch.observer — SEC 8-K summary
======================================

Issuer:     Janux Therapeutics, Inc. (JANX)
CIK:        0001817713
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001193125-26-187641
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Janux reclassifies director Eric Dobmeier from Class III to Class II to rebalance board classes
--------------------------------------------------------------------------------

- On April 28, 2026, Eric Dobmeier resigned as Class III director and immediately reappointed as Class II director.
- Change effective to achieve more equal balance among the three director classes on the Board.
- Dobmeier's service deemed uninterrupted for vesting, equity awards, and compensation purposes.
- Dobmeier continues on the Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817713/000119312526187641/0001193125-26-187641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817713/000119312526187641/janx-20260428.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-187641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer